Panniculitis induced by a chemotherapy regimen consisting of topotecan and cyclophosphamide

Pediatr Blood Cancer. 2005 Jan;44(1):98-9. doi: 10.1002/pbc.20194.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects*
  • Humans
  • Infant
  • Male
  • Mesna / administration & dosage
  • Mesna / pharmacology
  • Neoplasms, Germ Cell and Embryonal / drug therapy*
  • Panniculitis / chemically induced*
  • Panniculitis / pathology
  • Topotecan / administration & dosage
  • Topotecan / adverse effects*

Substances

  • Topotecan
  • Cyclophosphamide
  • Mesna